| Literature DB >> 19473490 |
Iain P Nicholson1, Jane S Sutherland, Tanya N Chaudry, Earl L Blewett, Peter A Barry, Mary Jane Nicholl, Chris M Preston.
Abstract
BACKGROUND: Human cytomegalovirus (HCMV) is a betaherpesvirus that causes severe disease in situations where the immune system is immature or compromised. HCMV immediate early (IE) gene expression is stimulated by the virion phosphoprotein pp71, encoded by open reading frame (ORF) UL82, and this transactivation activity is important for the efficient initiation of viral replication. It is currently recognized that pp71 acts to overcome cellular intrinsic defences that otherwise block viral IE gene expression, and that interactions of pp71 with the cell proteins Daxx and ATRX are important for this function. A further property of pp71 is the ability to enable prolonged gene expression from quiescent herpes simplex virus type 1 (HSV-1) genomes. Non-human primate cytomegaloviruses encode homologs of pp71, but there is currently no published information that addresses their effects on gene expression and modes of action.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19473490 PMCID: PMC2693105 DOI: 10.1186/1743-422X-6-65
Source DB: PubMed Journal: Virol J ISSN: 1743-422X Impact factor: 4.099
Figure 1Phylogenetic tree showing the relationships of UL82 homologs. A neighbour-joining tree was derived from the aligned amino acid sequences, and midpoint rooted.
HSV-1 in1312-based recombinants used in the study1
| Mutant | Transgenes expressed2 |
| None | |
| HCMV IE-lacZ (UL43) | |
| YFPpp71 (TK) | |
| YFPS82 (TK) | |
| YFPpp71 (TK), HCMV IE-lacZ (UL43) | |
| YFPS82 (TK), HCMV IE-lacZ (UL43) | |
| YFPRh82 (TK), HCMV IE-lacZ (UL43) | |
| YFPB82 (TK), HCMV IE-lacZ (UL43) | |
| YFPCh82 (TK), HCMV IE-lacZ (UL43) | |
| SCMV IE-lacZ (TK) | |
| HCMV IE-lacZ (TK) | |
| HSV ICP0-lacZ (TK) | |
| HCMV IE-Cre (TK) |
1. The parental mutant, in1312, has mutations that inactivate the transcriptional activities of HSV-1 proteins VP16, ICP0 and ICP4. The construction of the mutants is described in materials and methods.
2. The insertion site in the in1312 genome is shown in brackets.
Stimulation of gene expression by pp71 and S821
| Cells | Preinfection | Stimulation of β-galactosidase expression2 | ||
| HFFF2 | 0.7 | 0.9 | ND | |
| HFFF2 | 4.8 | 2.7 | ND | |
| HFFF2 | 4.8 | 3.3 | ND | |
| Vero | 0.6 | ND | ND | |
| Vero | 5.1 | 4.7 | ND | |
| Vero | 3.7 | 4.0 | ND | |
| 3T3 | 12.6 | 7.3 | 5.6 | |
| 3T3 | 10.8 | 6.6 | 4.3 | |
1. Monolayers were mock infected or infected with in1372 (a control virus that expresses Cre recombinase), in1316 (expresses pp71) or in1305 (expresses S82) at moi 2, incubated at 38.5°C for 3 h, and infected with a second reporter virus (moi 0.5) that contained the lacZ coding region controled by the HCMV MIEP (in1382), the SCMV MIEP (in1357) or the HSV-1 ICP0 IE promoter (in1383). After incubation for a further 5 h at 38.5°C, cell extracts were analysed for β-galactosidase activity.
2. The stimulation of β-galactosidase expression compared with the value for extracts of cells mock infected prior to infection with the reporter virus. Backgound activity from cells mock infected throughout was subtracted from all values. The means from at least two independent determinations are presented.
Figure 2Protein expression by . Monolayers of U373 cells were infected with 1 pfu/cell of in1374-based recombinants that expressed YFP-tagged UL82 homologs and maintained at 38.5°C for 10 h. At this time, extracts were analysed for protein levels, using anti-GFP or anti-actin antibodies as probes. Monolayers were infected with in1374 (lane 1), in1310 (lane 2), in0150 (lane 3), in0145 (lane 4), in0144 (lane 5), in0146 (lane 6) or mock infected (lane 7). Extracts were also analysed for β-galactosidase activity, as described in table 1.
Expression of β-galactosidase in cells expressing UL82 homologs1
| Virus | Protein expressed | β-galactosidase activity | |
| U373 | HFFF2 | ||
| YFPpp71 | 181 (20) | 240 (21) | |
| YFPS82 | 400 (20) | 450 (73) | |
| YFPB82 | 497 (0) | 521 (117) | |
| YFPRh82 | 353 (15 | 382 (94) | |
| YFPCh82 | 210 (10) | 243 (16) | |
| None | 0 (13) | 35 (2) | |
1. Monolayers of U373 cells or HFFF2 cells were infected with 1 pfu/cell (U373) or 5 pfu/cell (HFFF2) of in1374-based recombinants that expressed YFP-tagged UL82 homologs and maintained at 38.5°C for 10 h. At this time, extracts were prepared and assayed for β-galactosidase activity. Extracts were subsequently analyzed for protein production, as shown in figure 2. Background values (from mock infected cultures) were subtracted. The data presented here and in figure 2 are from the same lysates of a single experiment, and are representative of three independent experiments. The β-galactosidase activity from mock infected cells was subtracted from all values. The value in brackets is the maximum deviation from the mean of duplicate (U373) or triplicate (HFFF2) determinations.
Figure 3Long term expression of β-galactosidase. Monolayers of HFFF2 cells were infected with in1374-based recombinants (moi 3) and incubated at 38.5°C for 10 days in medium containing 2% fetal calf serum. Monolayers were stained for β-galactosidase activity on day 10 (top row), after superinfection with tsK on day 10 for 16 h (middle row), or after downshift to 32°C on day 10 and futher incubation for 4 days in medium containing 2% human serum (bottom row).
Figure 4Distribution patterns of UL82 homologs. Monolayers of HFFF2 cells were infected with in1374 derivatives expressing YFP-tagged homologs and analysed by immunofluorescence at 3 h or 7 h post infection at 38.5°C. Representative images are presented to demonstrate the three distribution patterns that were scored and quantified to produce the data presented in table 4.
Intranuclear distributions of UL82 homologs
| Protein | Distribution 3 h pi (% total) | Distribution 7 h pi (% total) | ||||
| Punctate | Mixed | Dispersed | Punctate | Mixed | Dispersed | |
| YFPpp71 | 97 | 3 | 0 | 70 | 29 | 1 |
| YFPS82 | 0 | 48 | 52 | 0 | 16 | 84 |
| YFPB82 | 84 | 16 | 0 | 26 | 39 | 35 |
| YFPRh82 | 84 | 15 | 1 | 64 | 28 | 8 |
| YFPCh82 | 90 | 10 | 0 | 38 | 40 | 22 |
HFFF2 monolayers were infected with in1374-based recombinants that expressed UL82 homologs, and maintained at 38.5°C. At 3 h pi and 7 h pi, cells were fixed and prepared for immunofluorescence. Distributions of proteins, as shown in figure 4, were scored for between 95 and 151 YFP-positive nuclei.
Figure 5Distribution patterns of UL82 homologs and ATRX. Monolayers of HFFF2 cells were infected with in1374 derivatives expressing YFP-tagged homologs and analysed by immunofluorescence at 3 h post infection at 38.5°C.
Intranuclear distributions of UL82 homologs and ATRX at 3 h pi
| Protein | Distribution of YFP (number) | Distribution of ATRX (number) | ||||
| Punctate | Mixed | Dispersed | Punctate | Mixed | Dispersed | |
| YFPpp71 | 23 | 2 | 0 | 0 | 4 | 21 |
| YFPS82 | 0 | 11 | 14 | 0 | 3 | 22 |
| YFPB82 | 22 | 3 | 0 | 1 | 2 | 22 |
| YFPRh82 | 21 | 4 | 0 | 0 | 2 | 23 |
| YFPCh82 | 20 | 5 | 0 | 1 | 7 | 17 |
HFFF2 monolayers were infected with in1374-based recombinants that expressed UL82 homologs, and maintained at 38.5°C. At 3 h pi, cells were fixed and prepared for immunofluorescence. Distributions of proteins, as shown in figure 4, were scored for 25 YFP-positive nuclei.